文献速递间质性肺疾病

疲劳严重度量表在真实世界间质性肺疾病队列中的效度和信度

Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

该研究在1881例间质性肺疾病(ILD)患者中评估疲劳严重度量表(FSS)的效度和信度。FSS内部一致性高(Cronbach's α=0.96),与患者报告结局锚点中度至强相关,与生理指标弱相关。FSS可用于评估ILD患者疲劳并区分不同疲劳程度。

要点

  • FSS在ILD患者中内部一致性高(Cronbach's α=0.96)。
  • FSS与患者报告锚点相关中至强,与肺功能及步行距离弱相关。
  • 使用家庭氧疗、口服激素及肺功能更差者FSS评分更高。

核心结论

  • 疲劳是ILD重要的以患者为中心结局,与肺功能及步行距离等生理指标相关性差。
  • FSS在ILD患者中具有可接受的测量性能,可区分不同疲劳程度。

研究设计与样本

  • 基于肺纤维化基金会患者登记处的1881例ILD患者,评估FSS效度和信度。
  • 锚点包括SF-6D健康效用指数及其活力问题、UCSD呼吸困难问卷、FVC、DLCO和6分钟步行距离。
  • 评估内部一致性信度、同时效度和已知组效度,并用验证性因子分析评估结构效度。

主要发现

  • FSS内部一致性高(Cronbach's α=0.96)。
  • FSS与SF-6D活力问题(r=0.55)和UCSD呼吸困难问卷总分(r=0.70)中度至强相关。
  • FSS与FVC(r=-0.24)、DLCO占预计值百分比(r=-0.23)和6分钟步行距离(r=-0.29)弱相关。
  • 使用补充氧疗、处方激素及FVC和DLCO占预计值百分比更低的患者FSS平均分更高。
  • 验证性因子分析提示FSS九个问题反映一个疲劳维度。

临床怎么用

  • 可将FSS用于ILD患者疲劳评估,并区分不同疲劳程度。
  • 解读FSS评分时应注意其与生理指标相关性弱,不能替代肺功能等客观评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Fatigue is a common and debilitating symptom for people living with interstitial lung disease (ILD). Studies on fatigue in ILD are limited, and little headway has been made toward developing interventions targeting the alleviation of fatigue. A barrier to progress is a lack of knowledge around the performance characteristics of a patient-reported outcome measure to assess fatigue in patients with ILD. Objectives: To assess the validity and reliability of the Fatigue Severity Scale (FSS) for measuring fatigue in a national cohort of patients with ILD. Methods: FSS scores and several anchors were measured in 1,881 patients from the Pulmonary Fibrosis Foundation Patient Registry. Anchors included the Short Form 6D Health Utility Index (SF-6D) score and a single vitality question from the SF-6D; the University of California, San Diego, Shortness of Breath Questionnaire; FVC; DlCO; and 6-minute-walk distance. Internal consistency reliability, concurrent validity, and known-groups validity were assessed. Structural validity was assessed using confirmatory factor analysis. Measurements and Main Results: The FSS demonstrated high internal consistency (Cronbach's α = 0.96). There were moderate to strong correlations between FSS score and patient-reported anchors (vitality question from the SF-6D [r = 0.55] and University of California, San Diego, Shortness of Breath Questionnaire total score [r = 0.70]) and weak correlations between FSS score and physiological measures (FVC [r = -0.24], percentage predicted DlCO [r = -0.23], and 6-minute-walk distance [r = -0.29]). Higher mean FSS scores, indicating greater fatigue, were observed among patients using supplemental oxygen, those prescribed steroids, and those with lower percentage predicted FVC and percentage predicted DlCO. The confirmatory factor analysis results suggest that the nine questions of the FSS reflect one dimension of fatigue. Conclusions: Fatigue is an important patient-centered outcome in ILD that is poorly correlated with physiological measures of disease severity, including lung function and walk distance. These findings further support the need for a reliable and valid measure of patient-reported fatigue in ILD. The FSS possesses acceptable performance characteristics for assessing fatigue and distinguishing different degrees of fatigue among patients with ILD.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Aronson KI, Martin-Schwarze AM, Swigris JJ, et al. Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort. Am J Respir Crit Care Med. 2023. PMID: 37099412. doi:10.1164/rccm.202208-1504OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。